Evidence map›Paper›PMID 24002089›Full record

ArticleAntimicrobial agents and chemotherapy2013

In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomallei.

Tereza de Jesus Pinheiro Gomes Bandeira, Camila Alencar Moreira, Raimunda Sâmia Nogueira Brilhante, Débora de Souza Collares Maia Castelo-Branco, Manoel Paiva de Araújo Neto, Rossana de Aguiar Cordeiro, Terezinha de Jesus Santos Rodrigues, Marcos Fábio Gadelha Rocha, José Júlio Costa Sidrim

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Treatment and prophylaxis of melioidosis.International journal of antimicrobial agents · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tereza de Jesus Pinheiro Gomes BandeiraSpecialized Medical Mycology Center, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Camila Alencar Moreira
Raimunda Sâmia Nogueira Brilhante
Débora de Souza Collares Maia Castelo-Branco
Manoel Paiva de Araújo Neto
Rossana de Aguiar Cordeiro
Terezinha de Jesus Santos Rodrigues
Marcos Fábio Gadelha Rocha
José Júlio Costa Sidrim
Universidade Federal do Ceará · BRUniversidade Estadual do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at investigating the in vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against Burkholderia pseudomallei in planktonic and biofilm forms, through broth microdilution and resazurin-based viability staining, respectively. In planktonic growth, the strains were susceptible to the drugs, while in biofilm growth, significantly higher antimicrobial concentrations were required, especially for ceftazidime and imipenem, surpassing the resistance breakpoints. These results highlight the importance of the routine evaluation of biofilm antimicrobial susceptibility.

Indexed as

Amoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsBiofilmsBrazilBurkholderia pseudomalleiCeftazidimeDoxycyclineDrug Resistance, Multiple, BacterialHumansImipenemMicrobial Sensitivity TestsPlanktonTrimethoprim, Sulfamethoxazole Drug CombinationAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsCeftazidimeDoxycyclineImipenemTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID24002089
PMCPMC3811307
OpenAlexW2117927635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.